# Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

> **NCT00952185** · NA · TERMINATED · sponsor: **City of Hope Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Lymphoproliferative Disorder
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Nonmalignant Neoplasm
- Viral Infection

## Interventions

- **OTHER:** cytology specimen collection procedure
- **OTHER:** fluorescent antibody technique
- **PROCEDURE:** assessment of therapy complications

## Key facts

- **NCT ID:** NCT00952185
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Very low enrollment and follow-up, cannot meet study objectives
- **Last updated:** 2015-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952185, "Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00952185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*